ICON is a Global Contract Research Organisation (CRO). We specialise in the strategic development, management and analysis of programs that support Clinical Development; from compound selection to Phase I-IV clinical studies.

Stock Price: ICLR (NASDAQ)
  • Last: $52.69
  • Change: 1.19
as of 4:15 PM ET on 30 Oct 2014
ICON Figures & Stock information »
Corporate Governance »
Calendar of Events »

Our services can be implemented separately or as part of a comprehensive full service clinical programme that can help expedite the time it takes to bring a drug to market and monitor its performance and safety post approval.

Learn more about which Industry Analysts cover ICON and other investment information
Click here to download electronic versions of ICON Reports and Proxy materials.